VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F10. A total of 1 filers reported holding VERTEX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $33,058,000 | +15.1% | 293,152 | -3.3% | 0.12% | +21.4% |
| Q2 2014 | $28,717,000 | +27.1% | 303,301 | -5.0% | 0.10% | +21.2% |
| Q1 2014 | $22,588,000 | -9.8% | 319,395 | -1.3% | 0.08% | -10.5% |
| Q4 2013 | $25,038,000 | +4.6% | 323,535 | +8.0% | 0.10% | -5.0% |
| Q3 2013 | $23,928,000 | +0.0% | 299,588 | 0.0% | 0.10% | -1.0% |
| Q2 2013 | $23,927,000 | – | 299,588 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2,982 | $354,000 | 0.00% |